The only other thing I'd say is that generally speaking we would always be trying, first of all, to keep our eye on the main objective, which is the health and safety of Canadians. Within that overarching objective, we also want to find ways of being as efficient as possible in doing our work.
We have, as you may be aware, Mr. Chair, eliminated a number of backlogs over the past year. We're always trying to improve our processes, and so streamlining, while not the ultimate objective.... To the extent that we can do our work more efficiently, we will.
An important part of that, given that all industrialized countries have some sort of drug regulatory approval and that we're all working largely on the same chemical entities, is the sharing of information and, where appropriate, some reciprocity. The more we can have that, the more efficient we'll be—always, at the end of the day, keeping the decision-making authority within Canadian hands.